Table 4 In vitro carbapenem susceptibility of the gram negative isolates (n = 1,043)
Gram-negative isolates | Number of isolates | Imipenem | Meropenem | Ertapenem | |||
|---|---|---|---|---|---|---|---|
Resistant n (%) | Sensitive/Unknown n (%) | Resistant n (%) | Sensitive/Unknown n (%) | Resistant n (%) | Sensitive/Unknown n (%) | ||
Escherichia coli | 361 | 17 (4.7) | 344 (95.3) | 12 (3.3) | 349 (96.7) | 12 (3.3) | 349 (96.7) |
Klebsiella pneumonia | 311 | 75 (24.1) | 236 (75.9) | 82 (26.4) | 229 (73.6) | 74 (23.8) | 237 (76.2) |
Acinetobacter baumannii | 164 | 131 (79.9) | 33 (20.1) | 137 (83.5) | 27 (16.5) | 122 (74.7) | 42 (25.6) |
Pseudomonas aeruginosa | 160 | 34 (21.2) | 126 (78.8) | 39 (24.4) | 121 (75.6) | 34 (21.2) | 126 (78.8) |
Proteus mirabilis | 30 | 1 (3.3) | 29 (96.7) | 1 (3.3) | 29 (96.7) | 0 (31.0) | 30 (100.0) |
Serratia marcescens | 10 | 0 (0.0) | 10 (100.0) | 0 (0.0) | 10 (100.0) | 0 (0.0) | 10 (100.0) |
Proteus vulgaris | 7 | 0 (0.0) | 7 (100.0) | 0 (0.0) | 7 (100.0) | 0 (0.0) | 7 (100.0) |